Log in

ASX:CUREETFs S&P Biotech ETF Units FP Stock Price, Forecast & News

-1.42 (-2.10 %)
(As of 05/13/2020)
Today's Range
Now: A$66.15
50-Day Range
MA: A$62.28
52-Week Range N/A
Volume2,243 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.76 out of 5 stars

Industry, Sector and Symbol

Industry N/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A

Receive CURE News and Ratings via Email

Sign-up to receive the latest news and ratings for CURE and its competitors with MarketBeat's FREE daily newsletter.

ETFs S&P Biotech ETF Units FP (ASX:CURE) Frequently Asked Questions

How has ETFs S&P Biotech ETF Units FP's stock been impacted by COVID-19 (Coronavirus)?

ETFs S&P Biotech ETF Units FP's stock was trading at A$53.15 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CURE shares have increased by 24.5% and is now trading at A$66.15. View which stocks have been most impacted by Coronavirus.

How often does ETFs S&P Biotech ETF Units FP pay dividends? What is the dividend yield for ETFs S&P Biotech ETF Units FP?

ETFs S&P Biotech ETF Units FP announced a Interim dividend on Wednesday, June 26th. Shareholders of record on Monday, July 15th will be given a dividend of 0.254 per share on Monday, July 15th. This represents a yield of 0.49%. The ex-dividend date of this dividend is Friday, June 28th. View ETFs S&P Biotech ETF Units FP's dividend history.

Has ETFs S&P Biotech ETF Units FP been receiving favorable news coverage?

News stories about CURE stock have trended somewhat negative on Saturday, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. ETFs S&P Biotech ETF Units FP earned a news sentiment score of -1.1 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutETFs S&P Biotech ETF Units FP.

What is ETFs S&P Biotech ETF Units FP's stock symbol?

ETFs S&P Biotech ETF Units FP trades on the ASX under the ticker symbol "CURE."

What is ETFs S&P Biotech ETF Units FP's stock price today?

One share of CURE stock can currently be purchased for approximately A$66.15.

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.